TherapeuticsMD Inc.

04/01/2026 | Press release | Distributed by Public on 04/01/2026 04:07

Amendment to Annual Report (Form 10-K/A)

This Amendment on Form 10-K/A ("Amendment No. 1") to our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with U.S. Securities and Exchange Commission on March 30, 2026, is being filed in order to correct printer errors in the following sections:

A printer error in the section entitled, "Item 12. Security ownership of certain beneficial owners and management and related stockholder matters" in Footnote 4.
Printer errors in the section entitled, "Item 15. Exhibits and financial statement schedules" to update and correct hyperlinks to certain exhibits and to add Footnote 34.
A printer error in the "Index to Financial Statements" to update and correct the Report of Independent Registered Public Accounting Firm and to delete a placeholder report.

Except as described above, there are no other changes contained in this Amendment No. 1, and we have not updated disclosures included therein to reflect any subsequent events.

TherapeuticsMD Inc. published this content on April 01, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 01, 2026 at 10:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]